We have been researching solutions to reduce global mortality from pneumonia for over 20 years. Supplying these fully human anti-pneumococcal monoclonal antibodies to the industry is unlocking new drug development and diagnostic possibilities to combat this illness
Meet Our Chief Science Officer
Micaela Scobie is the Chief Science Officer at Immune Diagnostics, where she directs research and product development, including oversight of research contracts, product growth, and scientific advancement within the company.
Micaela is an experienced scientist with a demonstrated history of working in the biotechnology industry. She is skilled in R&D, data analysis, and immunological assays, with a Ph.D. focused in Immunology from Clemson University. Micaela helps individuals and companies answer their research questions and develop strategies to accomplish these goals.